{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:32:35Z","timestamp":1792787555163,"version":"4.5.0"},"reference-count":49,"publisher":"American Association for Cancer Research (AACR)","issue":"11","funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2024YFA1802300"],"award-info":[{"award-number":["2024YFA1802300"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32320103009"],"award-info":[{"award-number":["32320103009"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82303130"],"award-info":[{"award-number":["82303130"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Youth Talent Support Program"},{"name":"Science & Technology Development Fund of Tianjin Education Commission for Higher Education","award":["2023KJ040"],"award-info":[{"award-number":["2023KJ040"]}]}],"content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,6,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Diffuse intrinsic pontine gliomas (DIPG) are lethal pediatric brain tumors that frequently harbor H3K27M mutations and lack effective treatments. In this study, our epigenomic analyses uncovered an enrichment of specificity protein\/Kr\u00fcppel-like factor\u00a0(SP\/KLF) transcription factors in open chromatin regions specifically in H3K27M-mutated DIPG cells compared with normal pontine neural progenitor cells. SP1 depletion or inhibition of SP\/KLF DNA binding with EC-8042, an optimized mithramycin analog, significantly suppressed the proliferation and invasiveness of H3K27M-DIPG cells. A screen of epigenetic drugs showed that histone deacetylase inhibitors (HDACi) synergized with EC-8042 to suppress H3K27M-DIPG cell growth. Unexpectedly, HDACis activated transcriptional programs that enhanced tumor adaptability and invasiveness, an effect counteracted by EC-8042. Mechanistically, HDACi treatment enhanced chromatin accessibility to SP\/KLF factors, whereas EC-8042 disrupted both the primary SP\/KLF transcription regulatory network and the HDACi-induced secondary network. Consequently, the combination treatment significantly impeded tumor progression in orthotopic xenograft models. Transcriptomic profiling indicated that this combinatorial strategy induced transcriptional changes associated with improved prognosis in patients with DIPG. Thus, this study identifies a therapeutic approach for H3K27M-mutated DIPGs and sheds light on the limitations of HDACis in treating solid tumors.<\/jats:p>\n                  <jats:p>Significance: The SP\/KLF transcriptional regulatory network is activated in H3K27M-mutated diffuse intrinsic pontine glioma and represents a promising therapeutic target in combination with HDAC inhibitors for combating these lethal pediatric brain tumors.<\/jats:p>","DOI":"10.1158\/0008-5472.can-24-2227","type":"journal-article","created":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T12:43:01Z","timestamp":1741351381000},"page":"2100-2116","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Targeting the SP\/KLF Transcriptional Regulatory Network Synergizes with HDAC Inhibition to Impede Progression of H3K27M Diffuse Intrinsic Pontine Glioma"],"prefix":"10.1158","volume":"85","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-5169-5483","authenticated-orcid":false,"given":"Yu","family":"Kong","sequence":"first","affiliation":[{"name":"1State Key Laboratory of Experimental Hematology, The Province and Ministry Co-sponsored Collaborative Innovation Center for Medical Epigenetics, Tianjin Key Laboratory of Medical Epigenetics, Key Laboratory of Immune Microenvironment and Disease (Ministry of Education), Department of Cell Biology, School of Basic Medical Sciences, Tianjin Medical University Cancer Institute and Hospital, Tianjin Medical University, Tianjin, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-9491-7883","authenticated-orcid":false,"given":"Fan","family":"Wang","sequence":"additional","affiliation":[{"name":"1State Key Laboratory of Experimental Hematology, The Province and Ministry Co-sponsored Collaborative Innovation Center for Medical Epigenetics, Tianjin Key Laboratory of Medical Epigenetics, Key Laboratory of Immune Microenvironment and Disease (Ministry of Education), Department of Cell Biology, School of Basic Medical Sciences, Tianjin Medical University Cancer Institute and Hospital, Tianjin Medical University, Tianjin, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-1310-8781","authenticated-orcid":false,"given":"Renwei","family":"Jing","sequence":"additional","affiliation":[{"name":"1State Key Laboratory of Experimental Hematology, The Province and Ministry Co-sponsored Collaborative Innovation Center for Medical Epigenetics, Tianjin Key Laboratory of Medical Epigenetics, Key Laboratory of Immune Microenvironment and Disease (Ministry of Education), Department of Cell Biology, School of Basic Medical Sciences, Tianjin Medical University Cancer Institute and Hospital, Tianjin Medical University, Tianjin, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-1884-717X","authenticated-orcid":false,"given":"Qian","family":"Zhao","sequence":"additional","affiliation":[{"name":"1State Key Laboratory of Experimental Hematology, The Province and Ministry Co-sponsored Collaborative Innovation Center for Medical Epigenetics, Tianjin Key Laboratory of Medical Epigenetics, Key Laboratory of Immune Microenvironment and Disease (Ministry of Education), Department of Cell Biology, School of Basic Medical Sciences, Tianjin Medical University Cancer Institute and Hospital, Tianjin Medical University, Tianjin, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1503-7506","authenticated-orcid":false,"given":"Xuejiao","family":"Lv","sequence":"additional","affiliation":[{"name":"1State Key Laboratory of Experimental Hematology, The Province and Ministry Co-sponsored Collaborative Innovation Center for Medical Epigenetics, Tianjin Key Laboratory of Medical Epigenetics, Key Laboratory of Immune Microenvironment and Disease (Ministry of Education), Department of Cell Biology, School of Basic Medical Sciences, Tianjin Medical University Cancer Institute and Hospital, Tianjin Medical University, Tianjin, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-6296-9435","authenticated-orcid":false,"given":"Yingying","family":"Zhao","sequence":"additional","affiliation":[{"name":"1State Key Laboratory of Experimental Hematology, The Province and Ministry Co-sponsored Collaborative Innovation Center for Medical Epigenetics, Tianjin Key Laboratory of Medical Epigenetics, Key Laboratory of Immune Microenvironment and Disease (Ministry of Education), Department of Cell Biology, School of Basic Medical Sciences, Tianjin Medical University Cancer Institute and Hospital, Tianjin Medical University, Tianjin, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-8844-7408","authenticated-orcid":false,"given":"Ye","family":"Yuan","sequence":"additional","affiliation":[{"name":"1State Key Laboratory of Experimental Hematology, The Province and Ministry Co-sponsored Collaborative Innovation Center for Medical Epigenetics, Tianjin Key Laboratory of Medical Epigenetics, Key Laboratory of Immune Microenvironment and Disease (Ministry of Education), Department of Cell Biology, School of Basic Medical Sciences, Tianjin Medical University Cancer Institute and Hospital, Tianjin Medical University, Tianjin, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-9363-9816","authenticated-orcid":false,"given":"Xianyou","family":"Xia","sequence":"additional","affiliation":[{"name":"1State Key Laboratory of Experimental Hematology, The Province and Ministry Co-sponsored Collaborative Innovation Center for Medical Epigenetics, Tianjin Key Laboratory of Medical Epigenetics, Key Laboratory of Immune Microenvironment and Disease (Ministry of Education), Department of Cell Biology, School of Basic Medical Sciences, Tianjin Medical University Cancer Institute and Hospital, Tianjin Medical University, Tianjin, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3568-2238","authenticated-orcid":false,"given":"Yu","family":"Sun","sequence":"additional","affiliation":[{"name":"2Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-2026-6938","authenticated-orcid":false,"given":"Yujie","family":"Tong","sequence":"additional","affiliation":[{"name":"3Department of Radiology, Tianjin Medical University General Hospital Tianjin, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-4007-0008","authenticated-orcid":false,"given":"Han","family":"Yan","sequence":"additional","affiliation":[{"name":"1State Key Laboratory of Experimental Hematology, The Province and Ministry Co-sponsored Collaborative Innovation Center for Medical Epigenetics, Tianjin Key Laboratory of Medical Epigenetics, Key Laboratory of Immune Microenvironment and Disease (Ministry of Education), Department of Cell Biology, School of Basic Medical Sciences, Tianjin Medical University Cancer Institute and Hospital, Tianjin Medical University, Tianjin, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9030-0626","authenticated-orcid":false,"given":"Qian","family":"Li","sequence":"additional","affiliation":[{"name":"1State Key Laboratory of Experimental Hematology, The Province and Ministry Co-sponsored Collaborative Innovation Center for Medical Epigenetics, Tianjin Key Laboratory of Medical Epigenetics, Key Laboratory of Immune Microenvironment and Disease (Ministry of Education), Department of Cell Biology, School of Basic Medical Sciences, Tianjin Medical University Cancer Institute and Hospital, Tianjin Medical University, Tianjin, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-0474-9038","authenticated-orcid":false,"given":"Ting","family":"Li","sequence":"additional","affiliation":[{"name":"1State Key Laboratory of Experimental Hematology, The Province and Ministry Co-sponsored Collaborative Innovation Center for Medical Epigenetics, Tianjin Key Laboratory of Medical Epigenetics, Key Laboratory of Immune Microenvironment and Disease (Ministry of Education), Department of Cell Biology, School of Basic Medical Sciences, Tianjin Medical University Cancer Institute and Hospital, Tianjin Medical University, Tianjin, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0443-2260","authenticated-orcid":false,"given":"Lei","family":"Cao","sequence":"additional","affiliation":[{"name":"1State Key Laboratory of Experimental Hematology, The Province and Ministry Co-sponsored Collaborative Innovation Center for Medical Epigenetics, Tianjin Key Laboratory of Medical Epigenetics, Key Laboratory of Immune Microenvironment and Disease (Ministry of Education), Department of Cell Biology, School of Basic Medical Sciences, Tianjin Medical University Cancer Institute and Hospital, Tianjin Medical University, Tianjin, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7346-3044","authenticated-orcid":false,"given":"Deng","family":"Liu","sequence":"additional","affiliation":[{"name":"1State Key Laboratory of Experimental Hematology, The Province and Ministry Co-sponsored Collaborative Innovation Center for Medical Epigenetics, Tianjin Key Laboratory of Medical Epigenetics, Key Laboratory of Immune Microenvironment and Disease (Ministry of Education), Department of Cell Biology, School of Basic Medical Sciences, Tianjin Medical University Cancer Institute and Hospital, Tianjin Medical University, Tianjin, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6144-7063","authenticated-orcid":false,"given":"Dawei","family":"Huo","sequence":"additional","affiliation":[{"name":"1State Key Laboratory of Experimental Hematology, The Province and Ministry Co-sponsored Collaborative Innovation Center for Medical Epigenetics, Tianjin Key Laboratory of Medical Epigenetics, Key Laboratory of Immune Microenvironment and Disease (Ministry of Education), Department of Cell Biology, School of Basic Medical Sciences, Tianjin Medical University Cancer Institute and Hospital, Tianjin Medical University, Tianjin, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6136-9969","authenticated-orcid":false,"given":"Shao-Kai","family":"Sun","sequence":"additional","affiliation":[{"name":"4School of Medical Imaging, Tianjin Medical University, Tianjin, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4702-6879","authenticated-orcid":false,"given":"Francisco","family":"Mor\u00eds","sequence":"additional","affiliation":[{"name":"5EntreChem SL, Vivero Ciencias de la Salud Calle Colegio, Oviedo, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7647-5780","authenticated-orcid":false,"given":"Yujie","family":"Tang","sequence":"additional","affiliation":[{"name":"6Key Laboratory of Cell Differentiation and Apoptosis of National Ministry of Education, Shanghai Key Laboratory of Reproductive Medicine, Department of Histoembryology, Genetics and Developmental Biology, Shanghai Jiao Tong University School of Medicine Shanghai, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9594-479X","authenticated-orcid":false,"given":"Xudong","family":"Wu","sequence":"additional","affiliation":[{"name":"1State Key Laboratory of Experimental Hematology, The Province and Ministry Co-sponsored Collaborative Innovation Center for Medical Epigenetics, Tianjin Key Laboratory of Medical Epigenetics, Key Laboratory of Immune Microenvironment and Disease (Ministry of Education), Department of Cell Biology, School of Basic Medical Sciences, Tianjin Medical University Cancer Institute and Hospital, Tianjin Medical University, Tianjin, China."},{"name":"7Department of Neurosurgery, Tianjin Medical University General Hospital, Tianjin, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2025,3,7]]},"reference":[{"key":"2025060203081773000_bib1","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/nrc3655","article-title":"Paediatric and adult glioblastoma: multiform (epi)genomic culprits emerge","volume":"14","author":"Sturm","year":"2014","journal-title":"Nat Rev Cancer"},{"key":"2025060203081773000_bib2","first-page":"153","article-title":"Pediatric high-grade glioma: biologically and clinically in need of new thinking","volume":"19","author":"Jones","year":"2017","journal-title":"Neuro Oncol"},{"key":"2025060203081773000_bib3","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.ccell.2018.11.015","article-title":"Histone H3.3 K27M accelerates spontaneous brainstem glioma and drives restricted changes in bivalent gene expression","volume":"35","author":"Larson","year":"2019","journal-title":"Cancer Cell"},{"key":"2025060203081773000_bib4","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.molcel.2020.09.028","article-title":"H3 K27M and EZHIP impede H3K27-methylation spreading by inhibiting allosterically stimulated PRC2","volume":"80","author":"Jain","year":"2020","journal-title":"Mol Cell"},{"key":"2025060203081773000_bib5","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1126\/science.1232245","article-title":"Inhibition of PRC2 activity by a gain-of-function H3 mutation found in pediatric glioblastoma","volume":"340","author":"Lewis","year":"2013","journal-title":"Science"},{"key":"2025060203081773000_bib6","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.ccr.2013.10.006","article-title":"Reduced H3K27me3 and DNA hypomethylation are major drivers of gene expression in K27M mutant pediatric high-grade gliomas","volume":"24","author":"Bender","year":"2013","journal-title":"Cancer Cell"},{"key":"2025060203081773000_bib7","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/nm.4293","article-title":"EZH2 is a potential therapeutic target for H3K27M-mutant pediatric gliomas","volume":"23","author":"Mohammad","year":"2017","journal-title":"Nat Med"},{"key":"2025060203081773000_bib8","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/ng.2936","article-title":"Genomic analysis of diffuse intrinsic pontine gliomas identifies three molecular subgroups and recurrent activating ACVR1 mutations","volume":"46","author":"Buczkowicz","year":"2014","journal-title":"Nat Genet"},{"key":"2025060203081773000_bib9","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/ng.2938","article-title":"The genomic landscape of diffuse intrinsic pontine glioma and pediatric non-brainstem high-grade glioma","volume":"46","author":"Wu","year":"2014","journal-title":"Nat Genet"},{"key":"2025060203081773000_bib10","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.ccell.2019.04.004","article-title":"Pervasive H3K27 acetylation leads to ERV expression and a therapeutic vulnerability in H3K27M gliomas","volume":"35","author":"Krug","year":"2019","journal-title":"Cancer Cell"},{"key":"2025060203081773000_bib11","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.molcel.2019.08.030","article-title":"Histone variant and cell context determine H3K27M reprogramming of the enhancer landscape and oncogenic state","volume":"76","author":"Nagaraja","year":"2019","journal-title":"Mol Cell"},{"key":"2025060203081773000_bib12","doi-asserted-by":"crossref","first-page":"2696","DOI":"10.1016\/j.molcel.2022.05.023","article-title":"Single-cell epigenetic analysis reveals principles of chromatin states in H3.3-K27M gliomas","volume":"82","author":"Harpaz","year":"2022","journal-title":"Mol Cell"},{"key":"2025060203081773000_bib13","doi-asserted-by":"crossref","first-page":"110836","DOI":"10.1016\/j.celrep.2022.110836","article-title":"H3-K27M-mutant nucleosomes interact with MLL1 to shape the glioma epigenetic landscape","volume":"39","author":"Furth","year":"2022","journal-title":"Cell Rep"},{"key":"2025060203081773000_bib14","doi-asserted-by":"crossref","first-page":"eabg7444","DOI":"10.1126\/sciadv.abg7444","article-title":"The H3K36me2 writer-reader dependency in H3K27M-DIPG","volume":"7","author":"Yu","year":"2021","journal-title":"Sci Adv"},{"key":"2025060203081773000_bib15","doi-asserted-by":"crossref","first-page":"108286","DOI":"10.1016\/j.celrep.2020.108286","article-title":"Senescence induced by BMI1 inhibition is a therapeutic vulnerability in H3K27M-mutant DIPG","volume":"33","author":"Balakrishnan","year":"2020","journal-title":"Cell Rep"},{"key":"2025060203081773000_bib16","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/nm.4296","article-title":"Therapeutic targeting of polycomb and BET bromodomain proteins in diffuse intrinsic pontine gliomas","volume":"23","author":"Piunti","year":"2017","journal-title":"Nat Med"},{"key":"2025060203081773000_bib17","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/nm0715-827a","article-title":"Functionally defined therapeutic targets in diffuse intrinsic pontine glioma","volume":"21","author":"Grasso","year":"2015","journal-title":"Nat Med"},{"key":"2025060203081773000_bib18","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.ccell.2019.09.005","article-title":"Re-Programing chromatin with a bifunctional LSD1\/HDAC inhibitor induces therapeutic differentiation in DIPG","volume":"36","author":"Anastas","year":"2019","journal-title":"Cancer Cell"},{"key":"2025060203081773000_bib19","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1093\/neuonc\/noab188","article-title":"Phase I\/II trial of vorinostat and radiation and maintenance vorinostat in children with diffuse intrinsic pontine glioma: a Children\u2019s Oncology Group report","volume":"24","author":"Su","year":"2022","journal-title":"Neuro Oncol"},{"key":"2025060203081773000_bib20","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1093\/neuonc\/noad141","article-title":"Phase I trial of panobinostat in children with diffuse intrinsic pontine glioma: a report from the Pediatric Brain Tumor Consortium (PBTC-047)","volume":"25","author":"Monje","year":"2023","journal-title":"Neuro Oncol"},{"key":"2025060203081773000_bib21","doi-asserted-by":"crossref","first-page":"4962","DOI":"10.1038\/s41467-024-49370-2","article-title":"Acetylation of histones and non-histone proteins is not a mere consequence of ongoing transcription","volume":"15","author":"Liebner","year":"2024","journal-title":"Nat Commun"},{"key":"2025060203081773000_bib22","doi-asserted-by":"crossref","first-page":"4877","DOI":"10.1093\/nar\/gkaa234","article-title":"Release of promoter-proximal paused Pol II in response to histone deacetylase inhibition","volume":"48","author":"Vaid","year":"2020","journal-title":"Nucleic Acids Res"},{"key":"2025060203081773000_bib23","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.ccell.2017.03.011","article-title":"Transcriptional dependencies in diffuse intrinsic pontine glioma","volume":"31","author":"Nagaraja","year":"2017","journal-title":"Cancer Cell"},{"key":"2025060203081773000_bib24","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.ebiom.2019.04.043","article-title":"Potent anti-tumor efficacy of palbociclib in treatment-na\u00efve H3.3K27M-mutant diffuse intrinsic pontine glioma","volume":"43","author":"Sun","year":"2019","journal-title":"EBioMedicine"},{"key":"2025060203081773000_bib25","doi-asserted-by":"crossref","first-page":"5876","DOI":"10.1158\/0008-5472.CAN-21-1456","article-title":"ALKBH5 facilitates hypoxia-induced paraspeckle assembly and IL8 secretion to generate an immunosuppressive tumor microenvironment","volume":"81","author":"Dong","year":"2021","journal-title":"Cancer Res"},{"key":"2025060203081773000_bib26","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1080\/15384101.2018.1469872","article-title":"Targeting of BMI-1 with PTC-209 inhibits glioblastoma development","volume":"17","author":"Kong","year":"2018","journal-title":"Cell Cycle"},{"key":"2025060203081773000_bib27","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jim.2009.06.008","article-title":"ELDA: extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays","volume":"347","author":"Hu","year":"2009","journal-title":"J Immunol Methods"},{"key":"2025060203081773000_bib28","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1093\/jmcb\/mjaa011","article-title":"Deregulation of tumor suppressive ASXL1-PTEN\/AKT axis in myeloid malignancies","volume":"12","author":"Cao","year":"2020","journal-title":"J Mol Cell Biol"},{"key":"2025060203081773000_bib29","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1038\/cr.2015.121","article-title":"Tumor suppressor ASXL1 is essential for the activation of INK4B expression in response to oncogene activity and anti-proliferative signals","volume":"25","author":"Wu","year":"2015","journal-title":"Cell Res"},{"key":"2025060203081773000_bib30","doi-asserted-by":"crossref","first-page":"4552","DOI":"10.1038\/s41467-018-06968-7","article-title":"PRMT2 links histone H3R8 asymmetric dimethylation to oncogenic activation and tumorigenesis of glioblastoma","volume":"9","author":"Dong","year":"2018","journal-title":"Nat Commun"},{"key":"2025060203081773000_bib31","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/j.molcel.2022.01.027","article-title":"CpG island reconfiguration for the establishment and synchronization of polycomb functions upon exit from naive pluripotency","volume":"82","author":"Huo","year":"2022","journal-title":"Mol Cell"},{"key":"2025060203081773000_bib32","doi-asserted-by":"crossref","first-page":"e63274","DOI":"10.7554\/eLife.63274","article-title":"Efficient chromatin accessibility mapping in situ by nucleosome-tethered tagmentation","volume":"9","author":"Henikoff","year":"2020","journal-title":"Elife"},{"key":"2025060203081773000_bib33","doi-asserted-by":"crossref","first-page":"2906","DOI":"10.1158\/2159-8290.CD-21-1492","article-title":"Epigenome programming by H3.3K27M mutation creates a dependence of pediatric glioma on SMARCA4","volume":"12","author":"Mo","year":"2022","journal-title":"Cancer Discov"},{"key":"2025060203081773000_bib34","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1038\/s41588-021-00897-w","article-title":"Simultaneous disruption of PRC2 and enhancer function underlies histone H3.3-K27M oncogenic activity in human hindbrain neural stem cells","volume":"53","author":"Brien","year":"2021","journal-title":"Nat Genet"},{"key":"2025060203081773000_bib35","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1186\/gb-2003-4-2-206","article-title":"Sp1- and Kr\u00fcppel-like transcription factors","volume":"4","author":"Kaczynski","year":"2003","journal-title":"Genome Biol"},{"key":"2025060203081773000_bib36","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.cell.2017.07.016","article-title":"Neural precursor-derived pleiotrophin mediates subventricular zone invasion by glioma","volume":"170","author":"Qin","year":"2017","journal-title":"Cell"},{"key":"2025060203081773000_bib37","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s40478-018-0553-x","article-title":"Non-inflammatory tumor microenvironment of diffuse intrinsic pontine glioma","volume":"6","author":"Lin","year":"2018","journal-title":"Acta Neuropathol Commun"},{"key":"2025060203081773000_bib38","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.ccell.2019.08.012","article-title":"Pervasive H3K27 acetylation leads to ERV expression and a therapeutic vulnerability in H3K27M gliomas","volume":"36","author":"Krug","year":"2019","journal-title":"Cancer Cell"},{"key":"2025060203081773000_bib39","doi-asserted-by":"crossref","first-page":"eaau5935","DOI":"10.1126\/sciadv.aau5935","article-title":"Multiple modes of PRC2 inhibition elicit global chromatin alterations in H3K27M pediatric glioma","volume":"4","author":"Stafford","year":"2018","journal-title":"Sci Adv"},{"key":"2025060203081773000_bib40","first-page":"91","article-title":"Effect of mithramycin on a mouse glioma","volume":"28","author":"Kennedy","year":"1968","journal-title":"Cancer Res"},{"key":"2025060203081773000_bib41","doi-asserted-by":"crossref","first-page":"964","DOI":"10.3390\/cancers12040964","article-title":"SOX2 expression and transcriptional activity identifies a subpopulation of cancer stem cells in sarcoma with prognostic implications","volume":"12","author":"Menendez","year":"2020","journal-title":"Cancers (Basel)"},{"key":"2025060203081773000_bib42","doi-asserted-by":"crossref","first-page":"e104687","DOI":"10.1371\/journal.pone.0104687","article-title":"Genome-wide modulation of gene transcription in ovarian carcinoma cells by a new mithramycin analogue","volume":"9","author":"Vizca\u00edno","year":"2014","journal-title":"PLoS One"},{"key":"2025060203081773000_bib43","doi-asserted-by":"crossref","first-page":"e30313","DOI":"10.1371\/journal.pone.0030313","article-title":"Mesenchymal transition and PDGFRA amplification\/mutation are key distinct oncogenic events in pediatric diffuse intrinsic pontine gliomas","volume":"7","author":"Puget","year":"2012","journal-title":"PLoS One"},{"key":"2025060203081773000_bib44","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.ccell.2017.09.014","article-title":"H3.3(K27M) cooperates with Trp53 loss and PDGFRA gain in mouse embryonic neural progenitor cells to induce invasive high-grade gliomas","volume":"32","author":"Pathania","year":"2017","journal-title":"Cancer Cell"},{"key":"2025060203081773000_bib45","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/ng.1102","article-title":"Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomas","volume":"44","author":"Wu","year":"2012","journal-title":"Nat Genet"},{"key":"2025060203081773000_bib46","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1016\/j.ejca.2005.08.006","article-title":"Sp transcription factor family and its role in cancer","volume":"41","author":"Safe","year":"2005","journal-title":"Eur J Cancer"},{"key":"2025060203081773000_bib47","doi-asserted-by":"crossref","first-page":"108994","DOI":"10.1016\/j.celrep.2021.108994","article-title":"Dual targeting of the epigenome via FACT complex and histone deacetylase is a potent treatment strategy for DIPG","volume":"35","author":"Ehteda","year":"2021","journal-title":"Cell Rep"},{"key":"2025060203081773000_bib48","doi-asserted-by":"crossref","first-page":"e2221175120","DOI":"10.1073\/pnas.2221175120","article-title":"Targeting SWI\/SNF ATPases in H3.3K27M diffuse intrinsic pontine gliomas","volume":"120","author":"Mota","year":"2023","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2025060203081773000_bib49","first-page":"2880","article-title":"BAF complex maintains glioma stem cells in pediatric H3K27M glioma","volume":"12","author":"Panditharatna","year":"2022","journal-title":"Cancer Discov"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/doi\/10.1158\/0008-5472.CAN-24-2227\/3554084\/can-24-2227.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/85\/11\/2100\/3608729\/can-24-2227.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/85\/11\/2100\/3608729\/can-24-2227.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T03:08:36Z","timestamp":1748833716000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/85\/11\/2100\/762567\/Targeting-the-SP-KLF-Transcriptional-Regulatory"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,7]]},"references-count":49,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025,3,7]]},"published-print":{"date-parts":[[2025,6,2]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-24-2227","relation":{},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,7]]}}}